Inocras

Summary active Updated Aug 4, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location San Diego, California
Founded 2019
Latest Stage Series B-3
Total Raised ~$100M
Website https://www.inocras.com
Sector
healthcare genomics oncology bioinformatics precision-medicine diagnostics

Founders

Jehee Suh CEO

About

Inocras is a San Diego-based bioinformatics firm specializing in whole-genome sequencing (WGS) and automated analytics for precision oncology 123. Its CLIA/CAP-certified platforms include CancerVision (tumor profiling) and MRDVision (molecular residual disease detection), already deployed across 100+ cancer institutions in Asia 12. The company is expanding U.S. commercial operations following the August 2026 financing 123.

Funding History

Date Round Amount Lead Co-investors
2026-08-03 Series B-3 $31M NDS Corporation, Aimed Bio IMM Investment, Korea Investment & Securities, LoftyRock Investment, DT& Investment, Woori Investment & Securities, Shinhan Securities 123

The oversubscribed round brings Inocras’s cumulative funding to approximately $100M and coincides with a joint research agreement with AimedBio to integrate WGS into AimedBio’s antibody-drug conjugate clinical programs 12.

What Investors Say

No independently sourced investor commentary quotes found beyond boilerplate press coverage at this time.

What Founders Say

No independently sourced founder testimonials found beyond boilerplate press coverage at this time.

Sources

  1. BusinessWire, “Inocras Closes $31 Million in Oversubscribed Series B-3 Financing to Accelerate U.S. Commercial Expansion,” August 3, 2026, accessed August 2026. https://www.businesswire.com/news/home/20260803380549/en/Inocras-Closes-$31-Million-in-Oversubscribed-Series-B-3-Financing-to-Accelerate-U.S.-Commercial-Expansion↩↩↩↩↩

  2. HIT Consultant, “Inocras Closes $31M for Whole-Genome Bioinformatics Platform,” August 3, 2026, accessed August 2026. https://hitconsultant.net/2026/08/03/inocras-raises-31m-series-b3-funding-whole-genome-oncology/↩↩↩↩↩

  3. FinSMEs, “Inocras Closes $31M Series B-3 Financing,” August 2026, accessed August 2026. https://www.finsmes.com/2026/08/inocras-closes-31m-series-b-3-financing.html↩↩↩